US Stock MarketDetailed Quotes
NYMXF Nymox Pharmaceutical
- 0.150
- +0.050+50.00%
15min DelayClose Nov 27 16:00 ET
14.03MMarket Cap-1500P/E (TTM)
0.150High0.073Low65.48KVolume0.073Open0.100Pre Close9.78KTurnover0.15%Turnover RatioLossP/E (Static)93.54MShares1.40052wk High-4.41P/B6.79MFloat Cap0.00052wk Low--Dividend TTM45.29MShs Float13.625Historical High--Div YieldTTM76.90%Amplitude0.000Historical Low0.149Avg Price1Lot Size
Nymox Pharmaceutical Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0.00%-5K | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | 0.00%-5K | --0 | --0 | --0 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Gross profit | 0 | 0 | 0 | 0 | 0.00%-5K | 0 | 0 | 0 | ||
| Operating expense | 25.53%8.35M | 387.66%4.85M | -31.53%1.01M | -38.06%1.1M | -72.70%1.39M | -46.80%6.65M | -160.47%-1.69M | -55.09%1.48M | -55.42%1.78M | 108.89%5.07M |
| Selling and administrative expenses | 51.30%4.36M | 390.47%2.83M | -40.07%353K | -47.62%506K | -10.14%665K | -50.75%2.88M | -60.51%577K | -59.63%589K | -49.58%966K | -26.29%740K |
| -Selling and marketing expense | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
| -General and administrative expense | 51.30%4.36M | 390.47%2.83M | -40.07%353K | -47.62%506K | -10.14%665K | -50.75%2.88M | -60.51%577K | -59.63%589K | -49.58%966K | -26.29%740K |
| Research and development costs | 5.86%3.99M | 189.26%2.02M | -25.90%661K | -26.67%594K | -83.39%720K | -43.33%3.77M | -270.54%-2.26M | -51.50%892K | -60.83%810K | 204.14%4.33M |
| Operating profit | -25.53%-8.35M | -388.52%-4.85M | 31.53%-1.01M | 38.06%-1.1M | 72.70%-1.39M | 46.80%-6.65M | 160.19%1.68M | 55.09%-1.48M | 55.42%-1.78M | -108.89%-5.07M |
| Net non-operating interest income expense | -30.95%-55K | 15.38%-22K | -120.00%-22K | -900.00%-10K | 83.33%-2K | -35.48%-42K | -30.00%-26K | -10K | 83.33%-1K | -20.00%-12K |
| Non-operating interest income | 500.00%6K | ---- | ---- | ---- | --2K | -87.50%1K | ---- | ---- | ---- | ---- |
| Non-operating interest expense | 41.86%61K | ---- | ---- | ---- | -66.67%2K | 10.26%43K | ---- | ---- | ---- | -45.45%6K |
| Total other finance cost | ---- | ---- | 120.00%22K | 900.00%10K | -66.67%2K | ---- | ---- | --10K | -83.33%1K | --6K |
| Other net income (expense) | -472.03%-439K | 6,000.00%118K | -3M | 3.12M | ||||||
| Gain on sale of security | -80.00%1K | ---- | ---- | ---- | ---- | 350.00%5K | ---- | ---- | ---- | ---- |
| Special income (charges) | ---440K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Less:Other special charges | --440K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | ---- | ---- | ---- | ---- | ---- | --113K | ---3M | ---- | --3.12M | ---- |
| Income before tax | -34.49%-8.84M | -296.64%-5.31M | 30.52%-1.04M | -182.84%-1.11M | 72.73%-1.39M | 47.55%-6.58M | 52.35%-1.34M | 54.79%-1.49M | 133.58%1.34M | -108.53%-5.09M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | -34.49%-8.84M | -296.64%-5.31M | 30.52%-1.04M | -182.84%-1.11M | 72.73%-1.39M | 47.55%-6.58M | 52.35%-1.34M | 54.79%-1.49M | 133.58%1.34M | -108.53%-5.09M |
| Net income continuous Operations | -34.49%-8.84M | -296.64%-5.31M | 30.52%-1.04M | -182.84%-1.11M | 72.73%-1.39M | 47.55%-6.58M | 52.35%-1.34M | 54.79%-1.49M | 133.58%1.34M | -108.53%-5.09M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -34.49%-8.84M | -296.64%-5.31M | 30.52%-1.04M | -182.84%-1.11M | 72.73%-1.39M | 47.55%-6.58M | 52.35%-1.34M | 54.79%-1.49M | 133.58%1.34M | -108.53%-5.09M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -34.49%-8.84M | -296.64%-5.31M | 30.52%-1.04M | -182.84%-1.11M | 72.73%-1.39M | 47.55%-6.58M | 52.35%-1.34M | 54.79%-1.49M | 133.58%1.34M | -108.53%-5.09M |
| Basic earnings per share | -42.86%-0.1 | -500.00%-0.06 | 50.00%-0.01 | -200.00%-0.01 | 66.67%-0.02 | 53.33%-0.07 | 66.67%-0.01 | 50.00%-0.02 | 120.00%0.01 | -100.00%-0.06 |
| Diluted earnings per share | -42.86%-0.1 | -500.00%-0.06 | 50.00%-0.01 | -200.00%-0.01 | 66.67%-0.02 | 53.33%-0.07 | 66.67%-0.01 | 50.00%-0.02 | 120.00%0.01 | -100.00%-0.06 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
